MedTrace Logo

Biologically Assisted Core Decompression of the Femoral Head Using the PerFuse Instrument and BioCUE

NCT02662881 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2021-10-20

No results posted yet for this study

Summary

This study will evaluate the performance of biologically assisted core decompression with the PerFuse instrument and BioCUE in patients with bone lesions in the femoral head. The study will explore the potential impact of patient demographics and baseline characteristics on post-operative outcomes.

Conditions

  • Avascular Necrosis of the Femoral Head

Interventions

DEVICE

PerFuse Percutaneous Decompression System

Core decompression with PerFuse

DEVICE

BioCUE Platelet Concentration System

PRP injection through the PerFuse cannula into core decompression site

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Principal Investigators

  • Christopher Travers, MD · Trustees of the University of Pennsylvania

  • Cecilia Pasucal-Garrido, MD · Washington University School of Medicine

  • Joseph Schwab, MD · Medical College of Wisconsin

  • Nicolas Piuzzi, MD · The Cleveland Clinic

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-31
Primary Completion
2020-12-08
Completion
2021-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02662881 on ClinicalTrials.gov